8-K ·Filed Jun 1, 2026

CYH

COMMUNITY HEALTH SYSTEMS INC
NEUTRAL
Impact 5/10
Horizonweeks Processed4mo ago SEC0001193125-26-251540
8-K material event: Items 2.01
Actionable Insight • Neutral

The divestiture is a modest deleveraging event that provides ~$107M in net cash proceeds, but the $55M pre-tax loss on sale and loss of $415M in annual revenue (~3.3% of total) suggest the assets were sold at a discount to carrying value. Monitor the post-closing working capital adjustment for potential further cash impact. The sale reduces CYH's geographic footprint but does not materially change the company's leverage profile (pro forma long-term debt remains $10.127B). Watch for additional hospital divestitures as CYH continues its portfolio rationalization strategy.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
CYH ▲ +5.04% at T+60d
NEUTRAL call ✓ call won +5.04% · α vs SPY +3.92% · entry $2.78 → $2.92
Entry anchored
Jun 1, 2026
via day open
T+1d
+0.72%
call +0.72% · α +1.44%
$2.80
settled 4mo ago
T+5d
+3.24%
call +3.24% · α +6.20%
$2.87
settled 4mo ago
T+20d
+27.34%
call +27.34% · α +28.90%
$3.54
settled 3mo ago
T+60d
+5.04%
call +5.04% · α +3.92%
$2.92
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Community Health Systems (CYH) completed the sale of four Arkansas hospitals (Northwest Medical Center - Bentonville, Northwest Medical Center - Springdale, Northwest Medical Center - Willow Creek Women's Hospital, and Siloam Springs Regional Hospital) and associated outpatient centers to Freeman Health System for $110 million in cash, subject to post-closing working capital adjustments. The transaction resulted in a pro forma pre-tax loss on sale of $55 million ($48 million after tax), and the divested operations generated approximately $415 million in annual revenue (3.3% of CYH's 2025 total revenue of $12.485 billion). The sale reduces CYH's hospital count from 64 to 60 affiliated hospitals and provides cash proceeds of ~$107 million net of transaction expenses, which will increase cash and cash equivalents to approximately $819 million on a pro forma basis.

Key Facts

  • Completed sale of 4 Arkansas hospitals to Freeman Health System for $110 million in cash
  • Purchase price after estimated working capital and finance lease assumption was $110 million, subject to post-closing adjustment
  • Pro forma pre-tax loss on sale of $55 million ($48 million after tax)
  • Divested operations generated ~$415 million in annual revenue (3.3% of CYH's total 2025 revenue of $12.485 billion)
  • Net cash proceeds of ~$107 million after $3 million in transaction expenses
  • Pro forma cash and cash equivalents increase to ~$819 million from $712 million
  • CYH retains 60 affiliated hospitals post-divestiture (down from 64)
  • Seller provided $78,614 credit for chiller repairs and $500,000 credit for environmental matters
  • 3-year non-compete covenant within 40-mile radius of the hospitals
  • Transition services agreements for IT, billing, and clinical operations post-closing

Financial Impact

Sale proceeds of $110 million cash; pro forma loss on sale of $55 million pre-tax ($48 million after tax); divested revenue of ~$415 million annually (3.3% of total); cash balance increases by ~$107 million net

revenuecashoperating incomeasset basehospital count

Risk Factors

  • Post-closing working capital adjustment could reduce net proceeds
  • Loss of $415M in annual revenue may pressure future earnings comparisons
  • Retained liabilities for pre-closing operations (medical malpractice, regulatory, tax) could result in future cash outflows
  • Transition services agreements create operational complexity and potential disputes
  • Environmental credits ($500K) may not fully cover remediation costs

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
13% bullish (16 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-251540
Document: cyh-ex99_1.htm0001193125-26-251540
Document: cyh-20260601.htm0001193125-26-251540
Document: cyh-ex99_2.htm0001193125-26-251540
Document: 0001193125-26-251540-index-headers.html0001193125-26-251540
Document: 0001193125-26-251540-index.html0001193125-26-251540
Document: 0001193125-26-251540.txt0001193125-26-251540
3 reports for CYH
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CYH — sortable, filterable
TypeNow
Jun 1, 2026
17w ago
8-K
NEUTRAL ★ 5/10
$2.78 $2.92▲ +5.04%▲ +3.92%$2.72 (−2.16%)
Apr 21, 2026
23w ago
8-K
BEARISH ★ 7/10
$2.71 $3.30▼ −21.77%▼ −16.99%$2.72 (−0.37%)
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 5/10
$3.35 $2.75▼ −17.91%▼ −30.69%$2.72 (−18.81%)
Showing 3 of 3

US Market Status

Market Closed — Opens Mon (64h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access